Tablet excipients 10 mark for pharmaceutical products development with mgr univerisity syllabus reference
Reading File
Finding Sources
Finding Sources
Finding Sources
Searching the Web
tablet excipients pharmaceutical product development MGR university syllabus 10 marks
I have the MGR University / PCI syllabus context. The library doesn't have a pharma-tech textbook, but I have all the content needed. Here is a complete 10-mark answer aligned with the MGR University B.Pharm Semester VIII - Pharmaceutical Product Development syllabus (Unit III).
Tablet Excipients - Pharmaceutical Product Development
(MGR University - B.Pharm Sem VIII, Unit III - 10 Marks Answer)
Definition
Excipients are pharmacologically inert substances added to a tablet formulation along with the active pharmaceutical ingredient (API). They serve functional roles in manufacturing, stability, bioavailability, and patient acceptability. The selection of excipients is a critical step in pharmaceutical product development.
Classification of Tablet Excipients
1. Diluents (Fillers)
Diluents provide bulk and weight to a tablet when the dose of the API is too small to form a compressible mass.
Ideal properties:
- Chemically inert, non-hygroscopic
- Good compressibility and flow
- Compatible with API
Examples:
| Type | Examples |
|---|---|
| Water-soluble | Lactose, Sucrose, Mannitol, Sorbitol |
| Water-insoluble | Dicalcium phosphate, Starch, Microcrystalline Cellulose (MCC) |
MCC (Avicel PH-101/102) is the most widely used diluent; it also acts as a binder and disintegrant (multifunctional excipient).
2. Binders (Adhesives)
Binders impart cohesiveness to the powder mass, ensuring the tablet maintains its integrity after compression.
Used in two ways:
- Dry binders - mixed with powder (e.g., MCC, HPMC)
- Solution binders (wet granulation) - added as solution to form granules
Examples:
| Binder | Concentration Used |
|---|---|
| PVP (Povidone) | 2-5% |
| HPMC (Hypromellose) | 2-5% |
| Starch paste | 5-10% |
| HPC (Hydroxypropyl Cellulose) | 2-6% |
| Gelatin | 1-3% |
| Acacia | 3-5% |
Mechanism: Binders form liquid bridges during wet granulation that solidify on drying, locking particles together.
3. Disintegrants
Disintegrants promote the breakup of the tablet into granules and fine particles after administration, facilitating drug dissolution and absorption.
Mechanisms of disintegration:
- Swelling - absorb water and swell (starch, croscarmellose)
- Wicking (capillary action) - draw fluid into the tablet matrix
- Deformation recovery - compressed particles return to their original shape
- Gas generation - CO2 produced (effervescent tablets: sodium bicarbonate + citric acid)
Examples:
| Disintegrant | Concentration | Mechanism |
|---|---|---|
| Sodium starch glycolate (Primojel) | 2-8% | Super-swelling |
| Croscarmellose sodium (Ac-Di-Sol) | 1-3% | Swelling + wicking |
| Crospovidone (Polyplasdone XL) | 2-5% | Wicking |
| Corn starch | 5-15% | Swelling |
Super-disintegrants (sodium starch glycolate, croscarmellose sodium, crospovidone) are used at lower concentrations with faster action. They are especially important in ODTs (Orally Disintegrating Tablets).
4. Lubricants, Glidants, and Anti-adherents
These are often grouped together but serve distinct purposes:
a) Lubricants
Reduce friction between the tablet and die wall during compression and ejection.
- Mechanism: Form a thin film between particles and metal surfaces
- Examples: Magnesium stearate (0.25-1%), Stearic acid, Sodium stearyl fumarate
- Note: Magnesium stearate is the most widely used but is hydrophobic - overuse reduces tablet dissolution
b) Glidants
Improve powder flow by reducing interparticulate friction.
- Examples: Colloidal silicon dioxide (Aerosil, 0.1-0.5%), Talc (1-5%)
c) Anti-adherents
Prevent sticking of tablet material to punch faces.
- Examples: Talc, Magnesium stearate, Starch
5. Directly Compressible (DC) Vehicles
These are specially processed excipients designed for direct compression tableting (without wet granulation). They combine properties of diluent, binder, and disintegrant.
Examples:
- Avicel (MCC) - most important DC vehicle
- Di-Tab (Dicalcium phosphate dihydrate)
- Starlac (lactose + starch spray-dried co-processed excipient)
- Ludipress (lactose + PVP + crospovidone)
- Spray-dried lactose
Advantages of DC vehicles: Eliminate granulation steps, reduce cost and time, suitable for moisture/heat-sensitive drugs.
6. Coating Materials (Coat Materials)
Used for film coating or sugar coating of tablets.
Film Coating Polymers:
| Type | Material | Purpose |
|---|---|---|
| Immediate release | HPMC, HPC, Ethylcellulose | Taste masking, appearance |
| Enteric coating | HPMCP, Eudragit L/S, CAP | Protect from gastric acid |
| Sustained release | Ethylcellulose, Eudragit RS/RL | Rate-controlled release |
Plasticizers (e.g., PEG, triethyl citrate, propylene glycol) are added to coat polymers to improve flexibility and prevent cracking.
7. Colouring, Flavouring, and Sweetening Agents
- Colorants: FD&C dyes, iron oxide pigments - used for product identification and aesthetics
- Flavouring agents: Peppermint oil, vanilla, fruit flavours - used in chewable and dispersible tablets
- Sweetening agents: Mannitol, sorbitol, saccharin, aspartame, sucralose - used in chewable, ODTs
8. Excipients for NDDS (Novel Drug Delivery Systems)
For controlled release and targeted delivery:
- Matrix formers: HPMC, Carbopol, Eudragit RLPO
- Osmotic pump excipients: Cellulose acetate, PEG, mannitol
- Mucoadhesive excipients: Carbopol 934P, HPMC, Chitosan
Selection Criteria for Tablet Excipients
- Compatibility with the API (no chemical interaction)
- Regulatory acceptance - listed in GRAS, pharmacopoeial standards (USP/IP)
- Concentration limits - use within established safe ranges
- Physicochemical properties - particle size, moisture content, flow, compressibility
- Availability and cost - pharmaceutical grade material
- Stability - excipient must be stable under storage and processing conditions
- Functional performance - tested by DSC, FTIR for compatibility
Compatibility Evaluation
Drug-excipient compatibility testing is conducted using:
- DSC (Differential Scanning Calorimetry) - detects thermal interactions/new peaks
- FTIR Spectroscopy - identifies new chemical bonds
- Accelerated stability studies - at 40°C/75% RH
Industrial Applications Summary
| Role | Excipient | Key Tablet Type |
|---|---|---|
| Diluent | Lactose, MCC | All tablet types |
| Binder | PVP, HPMC | Wet/dry granulated tablets |
| Disintegrant | Croscarmellose Na | Immediate release |
| Super-disintegrant | Sodium starch glycolate | ODT, fast-dissolve |
| DC vehicle | Avicel PH-102 | Direct compression tablets |
| Lubricant | Mg stearate | All tablets |
| Enteric coat | Eudragit L100 | Enteric-coated tablets |
| SR matrix | HPMC K100M | Extended-release tablets |
Key Points for Exam
- Excipients are broadly classified as: diluents, binders, disintegrants, lubricants/glidants, coating materials, colorants, and NDDS excipients
- Super-disintegrants (SSG, CCS, crospovidone) act by swelling and wicking
- MCC (Avicel) is the most versatile excipient - acts as diluent, binder, disintegrant, and DC vehicle
- Magnesium stearate is the most used lubricant but is hydrophobic - optimum mixing time is important
- Drug-excipient compatibility must always be evaluated by DSC and FTIR before finalizing a formulation
Syllabus reference: MGR University / PCI B.Pharm Semester VIII - Elective Course on Pharmaceutical Product Development, Unit III: "An advanced study of Pharmaceutical Excipients in pharmaceutical product development - Tablet and capsule excipients, Directly compressible vehicles, Coat materials, Excipients in parenteral and aerosol products, Excipients for formulation of NDDS."
What is eudragit L100
Finding Sources
Searching the Web
Eudragit L100 enteric coating polymer properties pharmaceutical
Eudragit L100
What is it?
Eudragit L100 is a synthetic, anionic methacrylic acid copolymer used as an enteric coating polymer in pharmaceutical formulations. It is manufactured by Evonik Industries (Germany) and is one of the most widely used enteric coating materials in tablet and capsule production.
Chemical Nature
| Property | Details |
|---|---|
| Chemical name | Poly(methacrylic acid-co-methyl methacrylate) 1:1 |
| Monomer ratio | Methacrylic acid : Methyl methacrylate = 1:1 |
| Type | Anionic copolymer |
| Functional group | Free carboxylic acid (-COOH) groups |
| Availability | White powder (organic soluble) |
The free carboxylic (-COOH) groups are responsible for its pH-dependent solubility - they remain protonated (unionized) in acidic gastric pH and ionize (form -COO⁻ salts) at higher pH, causing dissolution.
Key Property - pH-Dependent Solubility
This is the defining characteristic of Eudragit L100:
| pH | Behavior |
|---|---|
| < 6.0 (stomach, pH 1-2) | Insoluble - tablet protected, no drug release |
| ≥ 6.0 (duodenum/upper small intestine) | Dissolves - drug is released |
Dissolution threshold: pH 6.0 (upper small intestine / duodenum)
Eudragit Family Comparison
| Grade | Dissolution pH | Target Site |
|---|---|---|
| Eudragit L30 D-55 | pH ≥ 5.5 | Upper duodenum |
| Eudragit L100-55 | pH ≥ 5.5 | Duodenum |
| Eudragit L100 | pH ≥ 6.0 | Small intestine (upper) |
| Eudragit S100 | pH ≥ 7.0 | Ileum/colon |
| Eudragit FS 30D | pH ≥ 7.0 | Colon |
L and S grades can be combined to fine-tune the exact release site (e.g., L100 + S100 blend for mid-intestinal release).
Applications
1. Enteric Coating
The primary use. Protects:
- Acid-sensitive drugs: omeprazole, pantoprazole (proton pump inhibitors), enzymes, peptides, biologics
- Gastric mucosa from irritant drugs: NSAIDs like aspirin, diclofenac
- Delayed release of drugs that need to act in the intestine: mesalazine (for IBD/ulcerative colitis)
2. Coating Method
- Dissolved in organic solvents (isopropanol, acetone, ethanol/water mixtures)
- Applied by film coating pan or fluidized bed coater
- A plasticizer is required (e.g., diethyl phthalate, triethyl citrate, PEG 6000) to prevent cracking of the film
3. Other Applications
- Spray drying to form enteric microparticles/microspheres
- Hot melt extrusion for solid dispersions
- Granulation
Formulation Considerations
| Factor | Detail |
|---|---|
| Plasticizer | Mandatory - triethyl citrate (10-20% w/w of polymer), DBS, PEG |
| Minimum film thickness | ~40-100 µm for adequate gastric resistance |
| Polymer weight gain | Typically 5-10% w/w on the core tablet |
| Solvent system | Isopropanol:acetone or ethanol:water |
| Talc | Often added as anti-tacking agent (50% of polymer weight) |
| Pigments | TiO2, iron oxides can be incorporated |
Pharmacopoeial Status
Eudragit L100 is officially recognized as Methacrylic Acid Copolymer Type A in:
- USP/NF (United States Pharmacopoeia)
- Ph. Eur. (European Pharmacopoeia)
- JP (Japanese Pharmacopoeia)
It is listed in the GRAS (Generally Recognized as Safe) category and approved by USFDA for use in pharmaceutical products.
Advantages
- Precise pH-triggered release (narrow transition window)
- Fully synthetic - batch-to-batch consistency (unlike natural polymers)
- Compatible with most APIs
- Can be processed by multiple techniques
- No animal-derived ingredients - suitable for vegetarian/vegan formulations
Limitations
- Requires organic solvents (cost, safety, environmental issues) - though aqueous grades like L30 D-55 overcome this
- Needs plasticizer addition
- Hygroscopic in powder form - store in sealed containers at low humidity
Summary (One Line)
Eudragit L100 = anionic methacrylic acid-methyl methacrylate copolymer (1:1), insoluble at gastric pH, dissolves at pH ≥ 6.0, used as enteric coating for delayed drug release in the small intestine.
This is a shared conversation. Sign in to Orris to start your own chat.